Humoral rejection of organ allografts

American Journal of Transplantation

Volumn 5, Issue 11, 2005, Pages 2611-2618

  Moll, Solange ^a,b   Pascual, Manuel ^b,c  

^a Universitaire de Transplantation ^*

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Anti donor alloantibodies; C4d; Humoral rejection; Transplantation

Indexed keywords

ALLOANTIBODY; COMPLEMENT COMPONENT C4D; HLA ANTIGEN;

ALLOGRAFT; ANTIBODY PRODUCTION; CAPILLARY; GRAFT DYSFUNCTION; GRAFT REJECTION; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SHORT SURVEY; ACUTE DISEASE; ALLOTRANSPLANTATION; IMMUNOLOGY; PATHOLOGY; REVIEW;

ACUTE DISEASE; ANTIBODY FORMATION; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644789720     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01086.x     Document Type: Short Survey

References (59)

1. Jeannet M Pinn VW Flax MH Winn HJ Russell PS. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970 282: 111 117.
2. Halloran PF. The clinical importance of alloantibody-mediated rejection. Am J Transpl 2003 3: 639 640.
3. Halloran PF Wadgymar A Ritchie S Falk J Solez K Srinivasa NS. The significance of anti-class I antibody response. Clinical and pathologic features of anti-class I mediated rejection. Transplantation 1990 49: 85 91.
4. Halloran PF Schlaut J Solez K Srinivasa NS. The significance of anti-class I antibody response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992 53: 550 555.
5. Trpkov K Campbell P Pazderka F Cockfield S Solez K Halloran PF. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplantation 1996 61: 1586 1592.
6. Feucht HE Schneeberger H Hillebrand G et al. Capillary deposition of C4d complement fragment and early graft loss. Kidney Int 1993 43: 1333 1338.
7. Pascual M Saidman S Tolkoff-Rubin N et al. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 1998 66: 1460 1464.
8. Collins AB Schneeberger E Pascual M et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999 10: 2208 2214.
9. Crespo M Pascual M Tolkoff-Rubin N et al. Acute humoral rejection in renal allograft recipients: Incidence, serology and clinical characteristics. Transplantation 2001 71: 652 658.
10. Böhmig GA Exner M Habicht A et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002 13: 1091 1009.
11. Vongwiwatana A Tasanarong A Hidalgo LG Halloran PF. The role of B cells and alloantibody in the host response to human organ allografts. Immunol Rev 2003 196: 197 218.
12. Böhmig GA Regele H Exner M et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 2001 12: 2482 2489.
13. Regele H Böhmig GA Habicht A et al. Capillary deposition of complement split product C4d in renal allograft is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002 13: 2371 2380.
14. Lederer SR Kluth-Pepper B Schneeberger H Albert E Land W Feucht HE. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 2001 59: 334 341.
15. Herzenberg AM Gill JS Djurdjev O Magil AB. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 2002 13: 234 241.
16. Thurman JM Lucia MS Ljubanovic D Holers VM. Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int 2005 67: 524 530.
17. Haas M Ratner LE Montgomery RA. C4d staining of perioperative renal transplant biopsies. Transplantation 2002 74: 711 717.
18. Racusen LC Halloran PF Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant 2004 4: 1562 1566.
19. Regele H Exner M Watschinger B et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 2001 16: 2058 2066.
20. Mauiyyedi S Crespo M Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology and pathologic classification. J Am Soc Nephrol 2002 13: 779 787.
21. Shah A Nadasdy T Arend L et al. Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation 2004 77: 1399 1405.
22. Rocha PN Butterly DW Greenberg A et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 2003 75: 1490 1495.
23. White NB Greenstein SM Cantafio AW et al. Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection. Transplantation 2004 78: 772 774.
24. Min L Shuming J Zheng T et al. Novel rescue therapy for C4d-positive acute humoral renal allograft rejection. Clin Transplant 2005 19: 51 55.
25. Feucht HE Opelz G. The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 1996 50: 1464 1475.
26. Karpinski M Rush D Jeffery J et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 2001 12: 2807 2814.
27. Nickeleit V Zeiler M Gudat F Thiel G Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002 13: 242 251.
28. Montgomery RA Zachary AA Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match positive recipients. Transplantation 2000 70: 887 895.
29. Baid S Saidman SL Tolkoff-Rubin N et al. Managing the highly sensitized transplant recipient and B cell tolerance. Curr Opin Immunol 2001 13: 577 581.
30. Jordan SC Quartel AS Czer LS et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998 66: 800 805.
31. Glotz D Antoine C Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002 2: 758 760.
32. Jordan SC Tyan D Stablein D et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 2004 15: 3256 3262.
33. Pascual M Theruvath T Kawai T Tolkoff-Rubin N Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002 346: 580 590.
34. Halloran PF Melk A Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999 10: 167 181.
35. Ivanyi B Fahmy H Brown H Szenohradszky P Halloran PF Solez K. Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study. Hum Pathol 2000 31: 1129 1138.
36. Vongwiwatana A Gourishankar S Campbell PM Solez K Halloran PF Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004 4: 124 129.
37. Theruvath TP Saidman SL Mauiyyedi S et al. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 2001 72: 77 83.
38. Mauiyyedi S Pelle P Saidman S et al. Chronic humoral rejection: identification of antibody mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001 12: 574 582.
39. Cardarelli F Pascual M Tolkoff-Rubin N et al. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int 2005 18: 532 540.
40. Lee PC Terasaki PI Takemoto SK et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002 74: 1192 1194.
41. Mengel M Bogers J Bosmans JL et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transpl 2005 5: 1050 1056.
42. Vella JP Spadafora-Ferreira M Murphy B et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997 64: 795 800.
43. Sayegh MH. Why do we reject a graft¿ Role of indirect allorecognition in graft rejection. Kidney Int 1999 56: 1967 1979.
44. Watschinger B Pascual M. Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection. J Am Soc Nephrol 2002 13: 2420 2423.
45. Steele DJR Laufer TM Smiley ST et al. Two levels of help for B cell alloantibody production. J Exp Med 1996 183: 699 703.
46. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004 351: 2715 2729.
47. Williams JM Holzknecht ZE Plummer TB Lin SS Brunn GJ Platt JL. Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. Transplantation 2004 78: 1471 1478.
48. King KE Warren DS Samaniego-Picota M Campbell-Lee S Montgomery RA Baldwin WM. Antibody, complement and accommodation in ABO-incompatible transplants. Curr Opin Immunol 2004 16: 545 549.
49. Ishida H Tanabe K Ishizuka T Furusawa M Miyamoto N Ishikawa N. The mechanism responsible for accommodation after living-related kidney transplantations across the blood barrier. Transpl Intern 2005 18: 716 720.
50. Hammond EH Yowell RL Nunoda S et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 1989 8: 430 443.
51. Behr TM Feucht HE Richter K et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 1999 18: 904 912.
52. Michaels PJ Espejo MJ Kobashigawa J et al. Humoral rejection in cardiac transplantation: risk factors hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003 22: 58 69.
53. Poelzl G Ullrich R Huber A et al. Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy. Transplant Int 2005 18: 313 317.
54. Subherwal S Kobashigawa JA Cogert G Patel J Espejo M Oeser B. Incidence of acute cellular rejection and non-cellular rejection in cardiac transplantation. Transplant Proc 2004 36: 3171 3172.
55. Baldwin WM Samaniego-Picota M Kasper EK et al. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 1999 68: 894 900.
56. Magro CM Harman AP Klinger D et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Am J Transplant 2003 3: 1143 1154.
57. Magro CM Klinger DM Adams PW et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant 2003 3: 1264 1272.
58. Reznik SI Jaramillo A Zhang L Patterson GA Cooper JD Mohanakumar T. Anti-HLA antibody binding to HLA class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 2000 119: 39 45.
59. Krukemeyer MG Moeller J Morawietz L et al. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation 2004 78: 65 70.